PwC MoneyTree is the go-to source for Venture Capital firms and high growth startups.
In Q2 2017, investors deployed $18.4 billion to US VC-backed companies across 1,152 deals, jumping 27% in dollars from Q1 2017 but dipping 4% in deal terms. Funding activity was driven by a strong surge in mega-rounds of $100 million or more, with Q2 2017’s tally of 31 representing the highest total since the peak of 36 in Q3 2015. Meanwhile, deal activity remains in a lower range from the nearly 1,500 deals completed in Q3 2015.
PwC and CB Insights' Healthcare MoneyTree™ report brings you a quarterly publication based on US venture capital funding for healthcare related industries. Each issue is broken out by five key sections: US healthcare trends, US healthcare industries, US healthcare places, US healthcare movers and shakers, and Global healthcare trends.
The PwC MoneyTree website is home to the PwC/CB Insights quarterly MoneyTree Report. It contains historical trend data beginning with 1995, updates on the Venture Capital and high-growth startups ecosystem, and relevant insights from PwC’s emerging company services and venture capital tax, audit, and advisory experts. The PwC/CB Insights MoneyTree Report is the definitive source of information on venture capital investments in emerging companies. This study is a staple of the financial community, entrepreneurs, government policymakers and the business press worldwide.
"Q2 was a tale of two trends. US deal activity continued its multi-quarter downward trend, but the growth rate of investments in dollar terms accelerated from the first quarter. A surge in Mega-round deals, to the second highest level seen to date, helped drive a robust level of quarterly VC funding
This publication identifies and assesses activity and trends in both the US equity and US debt capital markets in 2016.
What challenges are Venture Capitals facing today?
What challenges are high growth startups facing today?
Read the current quarter MoneyTree press release
Find out the results of the latest Technology Deals Insights report
Check out the latest analysis on the PwC MoneyTree blog
Check out the latest insights on Technology deals
Partner, US Pharmaceuticals and Life Sciences
Tel: +1 (408) 817 5029